Advertisement

Topics

Mesothelioma Applied Research Foundation Company Profile

02:28 EST 14th December 2018 | BioPortfolio


News Articles [1082 Associated News Articles listed on BioPortfolio]

Kessler Foundation fellow wins grant to study behavioral motivations in children with ADHD

(Kessler Foundation) Joman Y. Natsheh, MD, PhD, postdoctoral fellow in Pediatric Neuroscience and Neuropsychology Research at Kessler Foundation, has received a $13,500 pilot award from Texas Woman's ...

A novel research partnership in AI to advance drug discovery, longevity and aging research

(Biogerontology Research Foundation) Biogerontology Research Foundation CSO to collaborate with Insilico Medicine and WuXi AppTec on a research study in artificial intelligence for drug discovery. The...

A novel research partnership in AI to advance drug discovery, longevity & aging research

(Biogerontology Research Foundation) Thursday, June 14, London, UK: Biogerontology Research Foundation CSO to collaborate with Insilico Medicine and WuXi AppTec on a research study in artificial intel...

ASN Foundation Grant Applications: Deadline Extended to December 7

The submission deadline for all ASN Foundation Grant Applications has been extended to Friday, December 7, at 2:00 p.m. EST. The ASN Foundation for Kidney Research funds clinical and basic research an...

CFA Institute Research Foundation Publishes 'The Future of Investment Management,' by Dr. ...

NEW YORK, Nov. 12, 2018 /PRNewswire/ -- The CFA Institute Research Foundation, a research arm of CFA Institute which sponsors independent, in-depth research on issues Read more...

Damon Runyon Cancer Research Foundation awards over $3.6 million to nine top clinical investigators

(Damon Runyon Cancer Research Foundation) The Damon Runyon Cancer Research Foundation named six new Damon Runyon Clinical Investigators at its spring 2018 committee review. The recipients of this pres...

Healthy Lung Month: Emerging Treatment Options for Mesothelioma Patients

Mesothelioma is a rare cancer that develops in the lining of the lungs, abdomen, or cardiovascular cavity. A 2017 study reported that the number of people affected by this rare cancer is between 2,400...

The Michael J Fox Foundation for Parkinson’s Research

In this interview, filmed at BioPharm in San Francisco, Dr Fintan Walton speaks with to Debi Brooks, Co-Founder of The Michael J Fox Foundation for Parkinson’s Research They discuss the foundation's...

PubMed Articles [1587 Associated PubMed Articles listed on BioPortfolio]

MUC21 is a novel, negative immunohistochemical marker for epithelioid mesothelioma for its differentiation from lung adenocarcinoma.

The process of differential diagnosis between epithelioid mesothelioma and lung adenocarcinoma has been progressing; however, there are no absolute immunohistochemical markers to definitively diagnose...

Neoantigenic potential of complex chromosomal rearrangements in mesothelioma.

Malignant pleural mesothelioma is a disease primarily associated with exposure to the carcinogen asbestos. Whereas other carcinogen-related tumors are associated with a high tumor mutation burden, mes...

A comparison of asbestos fiber potency and elongate mineral particle (EMP) potency for mesothelioma in humans.

We analyzed the mesothelioma mortality in cohorts of workers exposed to crocidolite, amosite, and chrysotile to estimate asbestos fiber potency for mesothelioma, using the method of Hodgson and Darnto...

Epidemiological surveillance of mesothelioma mortality in Italy.

Malignant mesothelioma (MM) is causally linked to asbestos exposure with an estimated etiological fraction of 80% or more.

Revised Modified RECIST Criteria for Assessment of Response in Malignant Pleural Mesothelioma (Version 1.1).

Malignant pleural mesothelioma poses unique difficulties in tumor measurement and response assessment; however, robust and reproducible assessment of response is critically important in the conduct, i...

Clinical Trials [3124 Associated Clinical Trials listed on BioPortfolio]

Mesothelioma Stratified Therapy (MiST) : A Multi-drug Phase II Trial in Malignant Mesothelioma

MiST is a British Lung Foundation funded, University of Leicester Study, a multi-arm stratified therapy based clinical trial for patients with relapsed mesothelioma. The goal of MiST is t...

Prospectively Collected Pleural Biopsies for Validation of Malignant Pleural Mesothelioma Prognostic Biomarkers

This research study is evaluating a new method for determining stage and prognosis of individuals with malignant pleural mesothelioma.

Mesothelin and Osteopontin as Diagnostic Markers in Patients With Mesothelioma or Atypical Mesothelial Hyperplasia

RATIONALE: Studying levels of mesothelin and osteopontin in samples of blood from patients with mesothelioma or atypical mesothelial hyperplasia may help doctors identify biomarkers relate...

Everolimus (RAD001) for the Treatment of Malignant Pleural Mesothelioma With Merlin/NF2 Loss as a Biomarker to Predict Sensitivity

For patients with malignant pleural mesothelioma that has grown despite treatment with standard chemotherapy, no treatment has yet proven beneficial. The purpose of this study is to find o...

SU5416 in Treating Patients With Malignant Mesothelioma

RATIONALE: SU5416 may stop the growth of malignant mesothelioma by stopping blood flow to the tumor. PURPOSE: Phase II trial to study the effectiveness of SU5416 in treating patients who ...

Companies [2905 Associated Companies listed on BioPortfolio]

The Mesothelioma Applied Research Foundation

The Meso Foundation is the only 501(c)(3) nonprofit organization dedicated to eradicating mesothelioma and easing the suffering caused by this cancer. The Meso Foundation actively...

Mesothelioma Applied Research Foundation

Baron & Budd, P.C. .

The national mesothelioma law firm of Baron & Budd, P.C. has a more than 30-year history of “Protecting What’s Right” for asbestos sufferers and their families. As ...

Simmons Firm

The Simmons Firm, headquartered in Alton, Ill., is one of the country’s leading asbestos and mesothelioma litigation firms. With offices in Illinois, Missouri and California,...

Simmons Browder Gianaris Angelides & Barnerd LLC

The Simmons Firm, headquartered in Alton, Ill., is one of the country’s leading asbestos and mesothelioma litigation firms. With offices in Illinois, Missouri and California,...

More Information about "Mesothelioma Applied Research Foundation" on BioPortfolio

We have published hundreds of Mesothelioma Applied Research Foundation news stories on BioPortfolio along with dozens of Mesothelioma Applied Research Foundation Clinical Trials and PubMed Articles about Mesothelioma Applied Research Foundation for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Mesothelioma Applied Research Foundation Companies in our database. You can also find out about relevant Mesothelioma Applied Research Foundation Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record